Neoleukin Therapeutics, Inc. (NLTX) financial statements (2022 and earlier)

Company profile

Business Address SUITE 360 - 1616 EASTLAKE AVE EAST
SEATTLE, WA 98102
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments142,467192,556143,09376,928108,085103,05974,482
Cash and cash equivalents142,467192,556143,09376,92852,03232,30139,526
Short-term investments    56,05370,75834,956
Other current assets1,5221,966     
Other undisclosed current assets  503237740426314
Total current assets:143,989194,522143,59677,165108,825103,48574,796
Noncurrent Assets
Finance lease, right-of-use asset200  
Operating lease, right-of-use asset10,76610,154770
Property, plant and equipment 3,5702,06040090584989
Long-term investments and receivables     50,04638,458
Long-term investments     50,04638,458
Intangible assets, net (including goodwill)128347567    
Intangible assets, net (excluding goodwill)128347567    
Other noncurrent assets1,9281,926     
Other undisclosed noncurrent assets6,252 3053599  
Total noncurrent assets:19,27415,9973,4274531,50450,89538,547
TOTAL ASSETS:163,263210,519147,02377,618110,329154,380113,343
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,0165,4943,1819727,5698,0723,025
Accounts payable5261,3231,6047026,0166,8602,205
Accrued liabilities1,227927339249 188128
Employee-related liabilities3,2633,2441,238211,5531,024692
Debt5549618 16153
Other liabilities    72066101
Other undisclosed current liabilities3,5652,3469443,6552,6511,3661,663
Total current liabilities:8,6367,8894,7434,62710,9569,5194,792
Noncurrent Liabilities
Long-term debt and lease obligation11,76311,414593    
Finance lease, liability67108146
Operating lease, liability11,69611,306447
Liabilities, other than long-term debt   319486197131
Other liabilities   319486197131
Other undisclosed noncurrent liabilities(11,696)(11,306)     
Total noncurrent liabilities:11,76311,414593319486197131
Total liabilities:20,39919,3035,3364,94611,4429,7164,923
Stockholders' equity
Stockholders' equity attributable to parent142,864191,216141,68772,67298,887144,664108,420
Additional paid in capital536,362524,022441,216302,759297,459293,111219,986
Accumulated other comprehensive loss    (70)(169)(290)
Accumulated deficit(393,498)(332,806)(299,529)(230,087)(198,502)(148,278)(111,276)
Total stockholders' equity:142,864191,216141,68772,67298,887144,664108,420
TOTAL LIABILITIES AND EQUITY:163,263210,519147,02377,618110,329154,380113,343

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   25,000   
Gross profit:   25,000   
Operating expenses(60,698)(41,554)(70,959)(57,624)(51,119)(37,645)(21,340)
Other undisclosed operating income 7,826     
Operating loss:(60,698)(33,728)(70,959)(32,624)(51,119)(37,645)(21,340)
Nonoperating income (expense)64511,5171,039936643(520)
Investment income, nonoperating19490    (52)
Foreign currency transaction gain (loss), before tax(1)5     
Other nonoperating income (expense)(12)(44)1,5181,043940644(369)
Interest and debt expense(12)(14)(1)(4)(4)(1) 
Other undisclosed income from continuing operations before equity method investments, income taxes 141441 
Loss from continuing operations before equity method investments, income taxes:(60,704)(33,277)(69,442)(31,585)(50,183)(37,002)(21,860)
Other undisclosed income from continuing operations before income taxes12      
Net loss available to common stockholders, diluted:(60,692)(33,277)(69,442)(31,585)(50,183)(37,002)(21,860)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(60,692)(33,277)(69,442)(31,585)(50,183)(37,002)(21,860)
Comprehensive loss:(60,692)(33,277)(69,442)(31,585)(50,183)(37,002)(21,860)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   7099121(286)
Comprehensive loss, net of tax, attributable to parent:(60,692)(33,277)(69,442)(31,515)(50,084)(36,881)(22,146)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: